Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

War on C Difficile Is Being Fought On Multiple Fronts

Jun 07 2019

• By Bridget Silverman

Clostridium difficile bacteria isolated on black background, 3D illustration. Bacteria which cause pseudomembraneous colitis and are associated with nosocomial antibiotic resistance - Illustration

Related Content

No Safety Shortcuts Under Breakthrough Designation, Synthetic Biologics Finds

Apr 26 2018

'Slow Money As Bad As No Money' – SMEs Struggle For Superbug Funds

Nov 09 2018

Full Steam Ahead At Ferring To Unlock Microbiome Potential For Reproduction

Jan 22 2019

Lyme Disease Vaccine Pushes Valneva To US Listing

Feb 11 2019

Vedanta Receives Cash Injection To Proceed With Microbiome-Derived Pipeline

Dec 27 2018

Microbiome Drug Development: An Investigation Into Challenges And Innovative Pipeline Approaches

Sep 12 2018

Related Companies

Summit Therapeutics Inc.

MGB Biopharma Limited

Ferring Pharmaceuticals

Rebiotix, Inc.

Pfizer Inc.

Merck & Co., Inc.

Actelion Pharmaceuticals Ltd.

Pharmacyclics, Inc.

Deinove SA

Deinove SA

Medpace Inc.

Catalent, Inc

Seres Therapeutics, Inc.

Theriva Biologics, Inc.

Valneva SE

Additional Topics

United States Research & Development Infectious Diseases BioPharmaceutical

More from R&D

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window